Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
Perinatal lethal osteogenesis imperfecta is the result of heterozygous mutations of the COL1A1 and COL1A2 genes that encode the alpha 1(I) and alpha 2(I) chains of type I collagen, respectively.
|
7643358 |
1995 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
We describe a dominant point mutation in the COL1A1 gene causing extremely severe osteogenesis imperfecta (OI type II/III) which was detected in the dermal fibroblasts of a proband, diagnosed by ultrasonography at 24 weeks of gestation.
|
8364588 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
Fibroblast cell strains from three infants with perinatal lethal osteogenesis imperfecta (OI) carry unique mutations in COL1A1 (the gene encoding the pro alpha 1(I) chain of type I procollagen) that impair chain association.
|
8349697 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
To provide additional data for genotype-phenotype analyses and to determine the proportion of mutations in the type I collagen genes among subjects with lethal forms of OI, we sequenced the coding and exon-flanking regions of COL1A1 and COL1A2 in a cohort of 63 subjects with OI type II, the perinatal lethal form of the disease.
|
18996919 |
2009 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
We identified two infants with lethal (type II) osteogenesis imperfecta (OI) who were heterozygous for mutations in the COL1A1 gene that resulted in substitutions of aspartic acid for glycine at position 220 and arginine for glycine at position 664 in the product of one COL1A1 allele in each individual.
|
7487936 |
1995 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogenesis imperfecta (type II B).
|
7679635 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
Perinatal lethal osteogenesis imperfecta is the result of heterozygous mutations of the COL1A1 and COL1A2 genes.
|
10627137 |
1998 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
We have characterized a mutation in a pro alpha 1(I) procollagen gene (COL1A1) that results in lethal (type II) osteogenesis imperfecta.
|
3016737 |
1986 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
BEFREE |
Amniotic fluid testing revealed a novel COL1A1 mutation (c.1840G>A; p.Gly614Arg).OI Type II diagnosis was made.
|
30408804 |
2019 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
Biomarker
|
disease |
CTD_human |
|
|
|
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
Biomarker
|
disease |
MGD |
Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice.
|
10608859 |
1999 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
Biomarker
|
disease |
MGD |
ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta.
|
18248096 |
2008 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GermlineCausalMutation
|
disease |
ORPHANET |
Nosology and classification of genetic skeletal disorders: 2010 revision.
|
21438135 |
2011 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
|
2339700 |
1990 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogenesis imperfecta (type II B).
|
7679635 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
|
2794057 |
1989 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.
|
3108247 |
1987 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.
|
1874719 |
1991 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures.
|
2036375 |
1991 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
To provide additional data for genotype-phenotype analyses and to determine the proportion of mutations in the type I collagen genes among subjects with lethal forms of OI, we sequenced the coding and exon-flanking regions of COL1A1 and COL1A2 in a cohort of 63 subjects with OI type II, the perinatal lethal form of the disease.
|
18996919 |
2009 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
|
8349697 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
RNA sequence analysis of a perinatal lethal osteogenesis imperfecta mutation.
|
2470760 |
1989 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.
|
3016737 |
1986 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
An RT-PCR-SSCP screening strategy for detection of mutations in the gene encoding the alpha 1 chain of type I collagen: application to four patients with osteogenesis imperfecta.
|
7691343 |
1993 |
Osteogenesis imperfecta, dominant perinatal lethal
|
0.890 |
GeneticVariation
|
disease |
UNIPROT |
A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.
|
3667599 |
1987 |